Synthesis and Biological Evaluation of a Series of Aromatic Bisphospohonates

dc.contributor.authorWasko, Brian
dc.date.accessioned2021-06-28T16:49:19Z
dc.date.available2021-06-28T16:49:19Z
dc.date.issued2010
dc.description.abstractGeminal bisphosphonates display varied biological activity depending on the nature of the substituents on the central carbon atom. For example, the nitrogenous bisphosphonates zoledronate and risedronate inhibit the enzyme farnesyl diphosphate synthase while digeranyl bisphosphonate has been shown to inhibit the enzyme geranylgeranyl diphosphate synthase. We now have synthesized isoprenoid olefins in an isoprenoid bisphosphonate and investigated the ability of these new compounds to impair protein geranylgeranylation with cells. Several of these new compounds are potent inhibitors of the enzyme geranylgeranyl diphosphate synthase.en_US
dc.identifier.citationBarney RJ, Wasko BM, Dudakovic A, Hohl RJ, and Wiemer DF. Synthesis and biological evaluation of a series of aromatic bisphosphonates. Bioorg Med Chem. 2010 Oct 15;18(20):7212-20.en_US
dc.identifier.urihttps://hdl.handle.net/10657.1/2567
dc.publisherBioorg Med Chemen_US
dc.subjectMeSH terms Binding Sites Cell Line, Tumor Diphosphonates / chemical synthesis Diphosphonates / chemistry* Diphosphonates / pharmacology Enzyme Inhibitors / chemical synthesis* Enzyme Inhibitors / chemistry Enzyme Inhibitors / pharmacology Farnesyltranstransferase / antagonists & inhibitors Farnesyltranstransferase / metabolism Geranyltranstransferase / antagonists & inhibitors Geranyltranstransferase / metabolism Humansen_US
dc.titleSynthesis and Biological Evaluation of a Series of Aromatic Bisphospohonatesen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Synthesis and Biological Evaluation of a Series of Aromatic Bisphosphonates.pdf
Size:
7.24 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: